What is TetraQ?

A leading Australian contract research organisation (CRO)
providing integrated preclinical drug developme...
Where is TetraQ?
                                                                            Brisbane
 Located at The Uni...
How was TetraQ founded?

4 Founders
Professors Ron Dickinson, Istvan Toth, Rod
Minchin & Maree Smith
 Internationally rec...
How is TetraQ structured?



          Centre for Integrated Preclinical Drug Development (CIPDD)


                      ...
What is the significance of TetraQ services?

 Assess potential therapeutic effects of the drug candidate in living
  org...
Why is this significant?



 Expensive exercise – $US 800 – 1200 million

 Long timelines – 10-15 yrs

 Huge risk of fa...
What are the services TetraQ provide?
  Assessment of:
 Efficacy:
     “Does it work?”
     Cell-based assays and anima...
Where does TetraQ fit into the drug development phases?

                                                                 ...
Efficacy – Biological Services

           Is the drug candidate effective against the target disease?

 Proof-of-concept...
Pharmaceutics

    Does the drug candidate have the right physical, chemical &
    biological properties to become a medic...
Toxicology
              TetraQ-Toxicology facilities are GLP recognised

    Is the drug candidate sufficiently safe to a...
ADME – Bioanalytic Services
              (absorption, distribution, metabolism elimination)

         TetraQ-ADME is GLP ...
What Clinical trail experience does TetraQ have?

HAHA Assay
     Transferred and validated HAHA assay (Human antibody/h...
Quality is Key!

 Our Quality System is maintained by a full-time Quality
  Assurance Manager who is supported by trained...
Who are TetraQ clients?

   Australian biotech and pharma companies
       ASX-listed & private companies
   Internatio...
Why use TetraQ Services?

 TetraQ offer Tailored solutions, not just a menu of choices

 Four world class facilities wit...
Thank you for your interest in TetraQ

                                    We are focused to provide preclinical drug
  De...
Upcoming SlideShare
Loading in...5
×

TetraQ - Integrated Preclinical Drug Development Solutions Presentation

1,864

Published on

TetraQ is a leading Australian preclinical contract research organization focused on providing a broad range of integrated preclinical drug development solutions in the disciplines of ADME, Bioanalytics, Efficacy, Toxicology and Pharmaceutics. TetraQ’s Toxicology, ADME and Bioanalytics laboratories are GLP recognised and in collaboration with NATA, TetraQ’s ADME team pioneered ISO17025-2005 (R&D) research & development accreditation becoming the first laboratory in Australia to obtain this accreditation in 2005.

Each of our world-class facilities is equipped with state-of-the-art instrumentation including LC-MS/MS, HPLC & ELISA. Essentially, TetraQ is a one-stop-shop for early stage drug development and we are recognized as world leaders in bioanalytical method development & sample analysis of drugs / metabolites in biological fluids with both human and animal samples.

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,864
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
91
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

TetraQ - Integrated Preclinical Drug Development Solutions Presentation

  1. 1. What is TetraQ? A leading Australian contract research organisation (CRO) providing integrated preclinical drug development services to the biotech and pharmaceutical industries where... Quality, Performance, Reliability and Value are more than just words to us... It’s everything! Quality Preclinical Drug Development Solutions
  2. 2. Where is TetraQ? Brisbane  Located at The University of Queensland in Brisbane (UQ), Queensland  Joint initiative of UQ, Qld Institute for Medical Research (QIMR) and Q-Pharm  Part funded by the Queensland Government Smart State Research Facilities Fund  8.1 M$ invested in State-of-the-art infrastructure  GLP recognized  Staffing – 30 FTE + casuals Quality Preclinical Drug Development Solutions
  3. 3. How was TetraQ founded? 4 Founders Professors Ron Dickinson, Istvan Toth, Rod Minchin & Maree Smith  Internationally recognized experts in the four core preclinical disciplines – • ADME • Efficacy • Toxicology • Pharmaceutics  100 yrs expertise & know-how amongst founders  60 yrs of commercialization experience amongst founders Quality Preclinical Drug Development Solutions
  4. 4. How is TetraQ structured? Centre for Integrated Preclinical Drug Development (CIPDD) Training The Hub of Organics Research Analysis Short courses for Targeted to bringing Commercial arm of Industry CIPDD; Business Bioanalysis Services innovation into Drug Development “Toolkit” undertaking contract for UQ researchers R&D for biotech & i.e. methods research Preclinical Seminars Pharma clients Modern GLP facilities with the latest Funded by research Training of PhD Registered business equipment and highly grants: Govt + Industry name of UniQuest - students working on trained technical staff “toolkit research” contracting entity for services to University of QLD researchers Quality Preclinical Drug Development Solutions
  5. 5. What is the significance of TetraQ services?  Assess potential therapeutic effects of the drug candidate in living organisms  Gather sufficient data to determine reasonable safety of the drug candidate in humans through laboratory experimentation and animal studies  Determine whether the drug candidate is ever likely to be developed as a pharmaceutical “Fail early, fail cheap” Quality Preclinical Drug Development Solutions
  6. 6. Why is this significant?  Expensive exercise – $US 800 – 1200 million  Long timelines – 10-15 yrs  Huge risk of failure  Only 1 in 5000 molecules from drug discovery will make it to market and become a new product Quality Preclinical Drug Development Solutions
  7. 7. What are the services TetraQ provide? Assessment of:  Efficacy:  “Does it work?”  Cell-based assays and animal models of human disease  ADME - Pharmacokinetics and metabolism:  “How can it be delivered and what does the body do to it?”  Absorption, distribution, metabolism, elimination (ADME)  Toxicology:  “Is it safe?”  Cell-based assays and animal testing  Pharmaceutics:  “Is its manufacture viable and controllable?”  Physicochemical properties; formulation studies, stability Quality Preclinical Drug Development Solutions
  8. 8. Where does TetraQ fit into the drug development phases? Phase Preclinical Phase I Phase II III Drug Drug Discovery Clinical Clinical Clinical Development Trials Trails Trails Quality Preclinical Drug Development Solutions
  9. 9. Efficacy – Biological Services Is the drug candidate effective against the target disease?  Proof-of-concept studies in animal models of human disease  Pain: nociceptive, inflammatory, neuropathic  Arthritis CNS Models - Multiple sclerosis, Parkinson‟s disease   Obesity  Diabetes  Cancer (through partner) Quality Preclinical Drug Development Solutions
  10. 10. Pharmaceutics Does the drug candidate have the right physical, chemical & biological properties to become a medicine for human use?  Physicochemical characterization  FTIR, UV,NMR,MS  Formulation development  Structure elucidation, solubility  Stability trials & stability indicating method development  Dissolution studies  Lead compound optimisation Quality Preclinical Drug Development Solutions
  11. 11. Toxicology TetraQ-Toxicology facilities are GLP recognised Is the drug candidate sufficiently safe to administer to humans in early stage clinical trials ?  Genotoxicity assays (Ames Test, Micronucleus, Mouse Lymphoma Assay)  In vivo acute & repeat dose (chronic) toxicity studies  In vivo safety pharmacology (including hERG, respiratory and CNS)  Cytotoxicity assessment  In vivo – two species, rodent and non rodent (dog, primates) Project Management Services  Preclinical development plans Quality Preclinical Drug Development Solutions
  12. 12. ADME – Bioanalytic Services (absorption, distribution, metabolism elimination) TetraQ-ADME is GLP recognised & has NATA ISO 17025, Research & Development Accreditation  World leaders in bioanalytical method development & sample analysis of drugs/metabolites in biological fluids, human and animal samples  Validated bioanalytical methods  HPLC, LC-MS/MS, ELISA  Screening, partially validated, fully validated to satisfy FDA requirements  Bioavailability and pharmacokinetic studies  Drug metabolism studies including metabolite identification  Biodistribution and plasma protein binding studies  Toxicokinetics Quality Preclinical Drug Development Solutions
  13. 13. What Clinical trail experience does TetraQ have? HAHA Assay  Transferred and validated HAHA assay (Human antibody/human antibody) and anaylsed 100‟s of samples ELISA Assay (Only Australian laboratory accredited for ELISA)  Transferred and conducted partial validation of ELISA assay for major Australian biotech organisations with analysis of 1500 plasma samples  LC-MS/MS - 3 synthetic peptides in a single vaccine  Fully validated in rat plasma to FDA requirements  Analysis of samples from Toxicokinetic study Small molecules - LC-MS/MS Bioequivalence studies for generics Quality Preclinical Drug Development Solutions
  14. 14. Quality is Key!  Our Quality System is maintained by a full-time Quality Assurance Manager who is supported by trained QA staff in each facility  TetraQ-ADME - NATA ISO 17025, Research & Development Accreditation  TetraQ-ADME and TetraQ-Toxicology are GLP recognised facilities  Data acceptable for Australian and international regulatory submission Quality Preclinical Drug Development Solutions
  15. 15. Who are TetraQ clients?  Australian biotech and pharma companies  ASX-listed & private companies  International clients  Based in USA, Europe, Asia & Japan  Universities, Research Institutes, Big Pharma  200 projects for 60 clients since inception in May 2005  Frequent repeat business  Indicates strong client satisfaction Quality Preclinical Drug Development Solutions
  16. 16. Why use TetraQ Services?  TetraQ offer Tailored solutions, not just a menu of choices  Four world class facilities with quot;State of the art” equipment including LC-MS/MS, HPLC and ELISA equipment  Highly skilled scientific and management team, Services backed by a leadership team with wealth experience in all 4 areas of preclinical drug development Quality science behind all services (no short cuts)  Modern PC2, SPF central animal breeding facilities  We assist clients with data interpretation to facilitate and guide timely decision-making  A „one-stop shop‟ for early stage drug development Quality Preclinical Drug Development Solutions
  17. 17. Thank you for your interest in TetraQ We are focused to provide preclinical drug Dean Simonsen - Sales & Services Manager development solutions to meet your needs - Mb: 61 409 480 532 - Email: d.simonsen@tetraq.com.au - PH: 61 7 3346 9933 - Fx: 61 7 3346 7391 Please feel free to ask questions to Rose-marie Pennisi better understand how we may assist - Commercial Manager - Mb: 61 437 112 549 your organisation - Email: r.pennisi@tetraq.com.au Quality Preclinical Drug Development Solutions
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×